We observed no differences in GPER expression between adenocarcinoma cell lines or tumors from male and female patients, similar to the previous findings of no difference in ERα or ERβ expression in NSCLC cells and tumors based on gender [20,68-70]. This evidence concerns the gene GPER1 and adenocarcinoma.